![](/img/cover-not-exists.png)
Effects of SREBF-1a and SCAP polymorphisms on plasma levels of lipids, severity, progression and regression of coronary atherosclerosis and response to therapy with fluvastatin
Lorraine Salek, Silvia Lutucuta, Christie M. Ballantyne, Antonio M. Gotto, A. MarianVolume:
80
Language:
english
Pages:
8
DOI:
10.1007/s00109-002-0381-z
Date:
November, 2002
File:
PDF, 212 KB
english, 2002